The pharmaceutical company does not admit guilt.
(Photo: dpa)
Washington The Bayer group has agreed to a multi-million dollar settlement in the USA because of alleged illegal commissions and misrepresentations in the marketing of certain drugs. Bayer will pay around $40 million to settle the case, the Justice Department said on Friday (local time) in Washington. The company did not admit guilt. $38.9 million of that goes to the United States and $1.1 million to 20 US states and Washington DC
Specifically, according to the announcement, it is about whistleblower complaints from a former marketing employee. She accused Bayer of fueling sales of two drugs by paying covert commissions (“kickbacks”) to hospitals and doctors. In addition, Bayer made false statements when selling and downplayed safety risks with a third drug. It’s about the drugs Trasylol, Avelox and Baycol.
More: In search of the new bestseller: Bayer makes a big bet on anticoagulants
Top jobs of the day
Find the best jobs now and
be notified by email.